Trial Profile
Functional RMN study to evaluate the prompt and middle term effect of the treatment with Donepezil in patients affected by multiple sclerosis and mild impairment of cognitive function.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 16 Mar 2012
Price :
$35
*
At a glance
- Drugs Donepezil (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- 03 Aug 2011 New trial record